A New Normal: Surveillance and Epidemiology of Severe Acute Respiratory Pathogens Using Multiplex PCR
Long before SARS-CoV-2 turned the world upside down, severe acute respiratory disease was already a major cause of morbidity and…
Seegene Unveils ‘Open Innovation Program Powered by Seegene’ in Partnership with Springer Nature
Together, we can create a disease-free future Register for the webcast - A replay will be available for those who…
Laboratory-Developed Tests: A Best Practices Primer
Laboratory-developed tests (LDTs) played a critical role during the COVID-19 pandemic. In fact, many current molecular tests were developed as…
Seegene Technologies, Inc. Announces Name Change to Seegene USA, Inc.
Company expands presence and support in US market. Proprietary TOCE™ technology overcomes PCR testing limitations for high multiplex applications. IRVINE,…
Celebrate DNA Day!
Congress approved the first National DNA Day in April 2003 to celebrate both the completion of the Human Genome Project…
The Pitfalls of At-Home COVID-19 Testing
Throughout the COVID-19 pandemic, identifying individuals who have been infected with SARS-CoV-2 in a reliable and timely manner has been…
Is the pandemic ending? Is COVID-19 now endemic?
After the global spikes in positive Omicron variant cases in December 2021 and January 2022, February saw a dip in…
The BA.2 Omicron Variant: Here’s What You Should Know
Although the “original” BA.1 subvariant of Omicron is the dominant form of the SARS-CoV-2 variant worldwide, a subvariant, BA.2 is…
What experts are saying about the flu-COVID-19 “twindemic”
In 2020, the news broke that the Pfizer and Moderna SARS-CoV-2 vaccines had reached historic milestones. This began the conversation…
Don’t Let Your Omicron Genes Drop Out: The Value of Variant-Specific Assays in Detecting New SARS-CoV-2 Strains
Image by Arek Socha from Pixabay The recently reported Omicron variant of SARS-CoV-2 has a 69-70del mutation in the S-gene…
The Omicron Variant: What We Know So Far
Image by Alexandra_Koch from Pixabay On Friday, November 26, the Omicron variant of SARS-CoV-2, the agent behind COVID-19 was classified as…
Respiratory Syncytial Virus: What You Need to Know About This Common Virus
Image by Luisella Planeta Leoni from Pixabay As temperatures begin to fall in many parts of the U.S., the onset of cold and…
The SARS CoV-2 Lambda Variant: Here’s What You Should Know
Image by Thiago Lazarino from Pixabay Like all RNA viruses, SARS-CoV-2 is prone to mutations—adaptive changes that can alter a…
Which COVID-19 Test Should You Use? A Comparison.
Image by fernando zhiminaicela from Pixabay With the introduction of vaccines and an abundance of testing options, the initial frenzied…
Can we get and stay ahead of COVID-19 and its variants?
By N. Mueller A year and a half into the SARS coronavirus (SARS-CoV-2) pandemic and we are still playing catchup.…
Catching Up With The COVID-19 Variants
According to the COVID tracking project, over 355 million tests have been performed in the United States as of March…
The Rapid Evolution of Seegene’s COVID-19 Solutions
It’s been one year since Seegene produced a complete respiratory diagnostic test that has taken the uncertainty out of differentiating…
The Future of Diagnostics: Syndromic Assays
How High Multiplex assays that test for many common pathogens at once can accelerate diagnostics and facilitate a higher quality…